CH
ICCC icon

CVI Holdings’s ImmuCell ICCC Stock Holding History

CVI Holdings’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,000
Closed -$64K – 67
2019
Q1 		$64K Buy
+10,000
New +$71.4K 0.06% 38

Other funds holding ICCC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CVI Holdings's ICCC Position: Q2 2019 in Review

CVI Holdings sold out of ImmuCell (ICCC) in Q2 2019, closing a stake of 10,000 shares — an estimated $64K sold.

CVI Holdings first reported a position in ICCC in Q1 2019 and held it in 1 quarter. The position peaked at $64K in Q1 2019. 23 funds tracked by Wall St. Rank hold ICCC as of Q2 2019.

  • CVI Holdings reported no remaining ImmuCell position as of Q2 2019 after selling out during the quarter.
  • CVI Holdings sold 10,000 ImmuCell shares in Q2 2019, an estimated $64K.
  • CVI Holdings first reported a position in ImmuCell in Q1 2019 and held it in 1 quarter.
  • CVI Holdings's ImmuCell position peaked at $64K in Q1 2019.
  • 23 funds tracked by Wall St. Rank held ImmuCell as of Q2 2019.

Based on CVI Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.